title: Warfarin embryopathy: patient, possibility, pathogenesis and prognosis.
authors.affiliation: Department of Pediatrics, Medical Centre Leeuwarden, The Netherlands.
authors.forename: T W
authors.initials: TW
authors.lastname: de Vries
authors.forename: E
authors.initials: E
authors.lastname: van der Veer
authors.forename: H S
authors.initials: HS
authors.lastname: Heijmans
mesh_terms: D000074:Acenocoumarol / Q000009:adverse effects*; D001842:Bone and Bones / Q000002:abnormalities; D002658:Developmental Disabilities / Q000139:chemically induced; D004338:Drug Combinations; D005260:Female; D005315:Fetal Diseases / Q000139:chemically induced*; D005865:Gestational Age; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D007231:Infant, Newborn; D007741:Labetalol / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D011239:Prednisolone / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011379:Prognosis; D012307:Risk Factors
chemical_list: D004338:Drug Combinations; D006852:Hydrochlorothiazide; D011239:Prednisolone; D000074:Acenocoumarol; D007741:Labetalol